Motoharu Abe
Overview
Explore the profile of Motoharu Abe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abe M, Kaneko K, Ueda A, Otsuka H, Shiosaki K, Nozaki C, et al.
Jpn J Infect Dis
. 2007 Nov;
60(6):342-6.
PMID: 18032831
General theories on the inactivation of viruses in the presence of a concentrated protein, such as the allantoic fluid of chicken eggs, are not useful. That is, although sodium hypochlorite...
2.
Abe M, Okada K, Hayashida K, Matsuo F, Shiosaki K, Miyazaki C, et al.
Microbiol Immunol
. 2007 Jun;
51(6):609-16.
PMID: 17579272
In paired serum samples collected from 17 children, we measured neutralizing antibody (NTAb) titers after the second series of routine Japanese encephalitis (JE) vaccination in Japan to estimate the duration...
3.
Abe M, Shiosaki K, Hammar L, Sonoda K, Xing L, Kuzuhara S, et al.
Virus Res
. 2006 Jul;
121(2):152-60.
PMID: 16815584
The persistent spread via animal reservoirs urges expanding vaccination programs against pathogens like the Japanese encephalitis virus, JEV. The JEV is spreads to new areas by domestic as well as...
4.
Kuzuhara S, Nakamura H, Hayashida K, Obata J, Abe M, Sonoda K, et al.
Vaccine
. 2003 Oct;
21(31):4519-26.
PMID: 14575762
The safety and effectiveness of a Vero cell-derived inactivated Japanese encephalitis (JE) vaccine were compared with those of a current JE vaccine in non-clinical studies and a phase I clinical...
5.
Abe M, Kuzuhara S, Kino Y
Vaccine
. 2003 Apr;
21(17-18):1989-94.
PMID: 12706688
We established a 50% plaque reduction analyzing method of neutralizing antibody for human serum to Japanese encephalitis virus (JEV) in Vero cells, called the '3 points least-squares regression method' (3LSRM)....
6.
Sugawara K, Nishiyama K, Ishikawa Y, Abe M, Sonoda K, Komatsu K, et al.
Biologicals
. 2002 Nov;
30(4):303-14.
PMID: 12421588
We have established a manufacturing system for a Vero cell-derived inactivated Japanese encephalitis vaccine at a 500l scale. The production system involves expansion of Vero cells using microcarrier, followed by...